I N T E R V I E W
development methods to Ayurveda . Herein , we derive hypotheses from traditional medicine systems but apply modern clinical standards to deliver safe , stable and effective medicines -- hopefully at prices that enable widespread access despite the high clinical costs associated with novel therapeutics . We believe this is uniquely achievable in India , if the right support is enabled by the regulators and government at large .
What milestones has been achieved by the company so far ?
Savikalpa Sciences is a nascent effort -- but some early milestones achieved are in the preclinical realm . We have completed in vitro investigations targeting inflammation response , analgesia , fibroblast proliferation , to name a few . We have also completed in vivo studies on a polyherbal topical formulation , which has shown higher anti-inflammatory and analgesic efficacy than almost all topical pain management products which contain diclofenac or lidocaine primarily . These results give us the confidence that we are on the right path -- further bolstered by the endorsement from a small cohort of doctors and patients we are working with who are consistently reporting treatment outcomes better than standard of care interventions .
Key product offerings of the
26
BioVoiceNews | October 2023